Abstract Canine parvovirus type 2 (CPV-2) has been reported worldwide as the main agent related to acute hemorrhagic enteritis of high morbidity and variable mortality in puppies. The detection and characterization of this virus is essential to understand the etiology of the disease and to develop control measures. To characterize the virus circulating in Peruvian dogs and to provide new insights into the local diversity of CPV-2, rectal swabs from 39 puppies with clinical symptoms and with no history of previous vaccinations were analyzed. Total DNA was extracted by fast boiling method, and PCR and sequencing were performed using specific primers that amplify a 1316 bp fragment corresponding to the VP2 gene of CPV-2. CPV-2 was detected in 62% of the analyzed samples.
The canine parvovirus virus (CPV) is a small (18-22 nm) non-enveloped negative single-stranded DNA virus that belongs to the Parvoviridae family. It is currently known that there are 2 types of canine parvovirus, CPV-1 and CPV-2, and three antigenic variants derived from CPV-2 identified so far: CPV-2a, CPV-2b and CPV-2c [3, 13] .
CPV-2 is antigenically and genetically closely related to Feline Panleukopenia virus (FPV), and its three antigenic variants (CPV-2a, CPV-2b and CPV-2c) are widely distributed and co-existing in European, South and North American countries [18] .
These variants are classified based on the amino acid at position 426 of the VP-2 protein: Asparagine (Asn, CPV2a), Aspartic acid (Asp, CPV-2b) and Glutamic acid (Glu, CPV-2c) [3] .
In South America, the first cases of canine hemorrhagic enteritis were observed in Chile [1] , and reports of variants of CPV-2 include countries such as Uruguay, Brazil, Chile and Argentina [4, 12, 14] . However, to the knowledge of the authors, there are no reports on genetic characterization of CPV isolates from Peru. In the present study, we characterized phylogenetically CPV-2 detected from dogs with suspected parvoviral infection by sequencing VP2 gene fragment and compared them with published CPV strains.
Rectal swabs from 39 puppies under 1 year of age, without history of vaccinations and with clinical diagnosis of canine parvovirus, were analyzed. The samples were obtained from March 2015 to January 2017 and came from veterinary clinics located in the city of Lima, the Peruvian capital.
Viral DNA extraction from swabs was performed using the fast boiling technique, as described by Schunck et al. [15] . A commercial vaccine was used as positive control.
All PCR amplification reactions for the VP2 gene fragment were performed using primers and under the conditions described by Ikeda et al. [11] to yield an amplicon of 1316 bp. PCR products were sequenced using bidirectional sequencing (Macrogen, Seoul, South Korea). The obtained chromatograms were checked on FinchTV 1.4.0 software (Geospiza, Seattle, WA, USA) and manually edited using BLAST program and BioEdit 7.1.3.0 software [7] . Edited sequences were joined using Contig Assembly Program (CAP) application [9] , aligned on Clustal W Multiple Alignment software [17] and compared with sequences of each variant from database at GenBank (NCBI). These sequences were exported to be analyzed on MEGA 6 software for phylogenetic analysis [16] . JModel Test was used to determine the best substitution model for nucleotide analysis. The phylogenetic tree was generated by the Maximum Likelihood method with Bootstrap values calculated in 1000 replicates. Predicted amino acid sequences were analyzed to determine the presence of asparagine (CPV-2a), aspartic acid (CPV-2b) or glutamic acid (CPV2c) in the position 426.
VP2 gene fragment amplification was achieved in 62% (24/39) of samples. Sequencing of the 1316 bp PCR product was performed in 9 samples with CPV-2 ( Table 1) . The obtained sequences were analyzed phylogenetically using Hasegawa-Kishino-Yano (HKY) as substitution model. Phylogeny revealed two well-supported clades, one containing CPV-2c strains from Uruguay, Ecuador, USA and Peru, and the other comprising CPV-2a strains from Uruguay, Ecuador, Brazil and Peru. Four of the sequenced samples were identified as 2a variant, whereas the others were classified as 2c (Fig. 1) . Comparison of the predicted amino acid sequences of 2c variants obtained in this study showed 100% similarity among them and with strains from Uruguay, Ecuador and the United States. The 2a strains were similar between them (except by the strain PER6) and 100% similar to isolates from Portugal, Brazil and New Zealand. The strain CPV-2c PER6 showed a mutation that originated a change at 440 amino acid position, which consisted in the substitution from a threonine (Thr) to serine (Ser). CPV VP2 is the major structural protein and is important for the determination of antigenic variants based on the variations in the amino acid sequence [5] . Several mutations on the capsid protein from the original CPV-2 were detected, that puts in evidence, for the first in Peru, the existence of two antigenic variants that can have a potential negative impact on dogs and wild animals. In Peru, the presence of canine parvovirus was confirmed by Hung et al. [10] ; however, the antigenic variants are unknown so far. Here, it has been shown the presence of two variants currently circulating in Peru, CPV-2a and CPV-2c, verified by the presence of, respectively, glutamic acid and asparagine at the 426 position in the amino acid sequence. CPV2b types were not found in this study, and this is in concordance with other reports that mention 2a and 2c as the predominant variants in South America [2, 4, 12] .
CPV-2c is the most prevalent variant in South America, and many reports reveal the existence of this variant on South America since 2007 that were reported in different countries from this continent, such as Brazil, Uruguay, Argentina and Ecuador [2, 4, 12, 14] . CPV-2c has also been found widespread in North American, European and Asiatic countries [6, 8] .
In addition to CPV-2c, CPV-2a variant was detected in countries in South America such as Brazil, Argentina, Uruguay and less frequently in Ecuador [2, 4, 12, 14] , although Pérez et al. [12] suggested the emergence of this variant in Uruguay.
The phylogenetic analysis showed that Peruvian CPV2a strains were grouped in one cluster with sequences from 
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Ecuador and New Zealand, and represents an exclusive lineage in South America. Likewise, Peruvian CPV-2c strains were clustered with strains from Ecuador, United States and Uruguay (Fig. 1) . The similarity of predicted amino acid sequence and phylogenetic analysis at the level of VP2 sequence confirms a homology of 100% of our strains of 2a antigenic variant with strains from Brazil, New Zealand and Europe but not with strains from Uruguay and Ecuador. Likewise, the strains of 2c antigenic variant had 100% similarity with strains from Uruguay and Ecuador. The phylogenetic analysis of amino acids (data not shown) revealed the existence of subgroups within each antigenic variant; where the strains were identical to each other, with exception of the strain PER6 of the variant CPV-2c, which presented a change in an amino acid at the position 440 of the predicted amino acid sequence (Thr-Ser).
Changes in few amino acids can generate conformational changes on the complete protein, leading to the ineffectiveness of the neutralizing antibodies induced by vaccine strains. Some authors [2, 13, 14] have previously observed Thr-Ser mutations at the position 440 only in CPV 2a and 2b sequences. They described the 440 position in the predicted amino acid sequence as the main antigenic site and as highly variable. In this study, for the first time, the mutation Thr-Ser was detected in a 2c strain (PER6).
Although only 9 sequences were analyzed in this study, the results demonstrated the coexistence of CPV-2a and 2c variants in Peruvian dogs, and the necessity of the inclusion of CPV-2c strain in vaccination programs in order to prevent and control CPV-2 infection.
